Li Y et al.Mitochondrial pyruvate carrier function is negatively linked to Warburg phenotype in vitro and malignant features in esophageal squamous cell carcinomas.Oncotarget 8:1058-1073 (2017).
Yang HJ et al.Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation.Transl Oncol 9:583-591 (2016).
Li Y et al.PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence.Oncotarget 7:53837-53852 (2016).
Pertega-Gomes N et al.A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.J Pathol 236:517-30 (2015).
Yao M et al.Dicer mediating the expression of miR-143 and miR-155 regulates hexokinase II associated cellular response to hypoxia.Am J Physiol Lung Cell Mol Physiol 307:L829-37 (2014).
Kim HM et al.Site-specific metabolic phenotypes in metastatic breast cancer.J Transl Med 12:354 (2014).
Chang HT et al.Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy.Nutr Metab (Lond) 10:47 (2013).